vimarsana.com
Home
Live Updates
Menu Hover - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Menu hover - Page 1 : vimarsana.com
China s NMPA accepts Legend Biotech s NDA for cilta-cel - Pharmaceutical Business review
Cilta-cel is a BCMA-directed and genetically modified autologous T-cell immunotherapy that involves reprogramming a patient’s own T-cells with a transgene encoding a chimeric antigen receptor (CAR), which detects
Menu hover
Subchild level menu hover
Child level menu hover
End third level
Bend article
End timeline
Vistagen agrees to acquire Pherin Pharmaceuticals
Vistagen has signed a definitive agreement for the acquisition of clinical-stage drug development firm Pherin Pharmaceuticals.
Shawn singh
Pherin pharmaceuticals
Robina weermeijer
Menu hover
Subchild level menu hover
Child level menu hover
End third level
Bend article
End timeline
FDA grants fast track designation for Kintara s breast cancer therapy
The US FDA has granted fast track designation (FTD) for Kintara Therapeutics’ REM-001, to treat cutaneous metastatic breast cancer (CMBC).
Menu hover
Subchild level menu hover
Child level menu hover
End third level
Bend article
End timeline
Everest regulatory updates in Taiwan, South Korea for Nefecon
The regulatory authorities in Taiwan and South Korea have granted fast-tracked approval process for Everest Medicines’ Nefecon.
Menu hover
Subchild level menu hover
Child level menu hover
End third level
Bend article
End timeline
ViiV Healthcare, Medicines Patent Pool partner to expand HIV drug access
ViiV Healthcare and the Medicines Patent Pool (MPP) have entered into a voluntary licensing agreement to expand access to cabotegravir
Charles gore
Deborah waterhouse
Sustainable development goal
National cancer institute on unsplash
Drug administration
Medicines patent pool
National cancer institute
Sub saharan african
Menu hover
Subchild level menu hover
Child level menu hover
vimarsana © 2020. All Rights Reserved.